PHS Capital

PHS Capital is a venture capital firm headquartered in Amsterdam. It invests in technology-enabled solutions focused on individual-centric health, wellness, and lifestyle sectors across Europe and North America.

Erik De Heus

Partner

Stephen Seuntjens

Partner

7 past transactions

SkinVision

Series B in 2018
SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.

Pacifica Labs

Seed Round in 2017
Pacifica Labs, Inc. is a San Francisco-based company that specializes in developing a mental health maintenance application aimed at helping individuals manage stress, anxiety, and worry. Founded in 2014, the company's mobile application integrates cognitive behavioral therapy and mindfulness techniques to empower users to take control of their mental health on a daily basis. The app offers tools for daily mood tracking, guided relaxation, meditation practices, and access to peer support groups, effectively making mental health care part of users' daily routines. By promoting awareness and self-efficacy, Pacifica provides a comprehensive and accessible solution for individuals seeking to manage their emotional well-being, regardless of whether they are currently in treatment.

SkinVision

Series A in 2015
SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.

machtfit

Series A in 2015
machtfit operates an online platform connecting companies, employees, and providers of health-promoting services. Its platform enables employees to discover and book health and fitness courses nationwide, access employer-subsidized benefits, and find comprehensive wellness resources. For enterprises, the platform offers tools to integrate their own offerings, manage employee health budgets, track usage statistics, communicate with employees, and customize the platform's appearance.

SkinVision

Series A in 2015
SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.

machtfit

Seed Round in 2013
machtfit operates an online platform connecting companies, employees, and providers of health-promoting services. Its platform enables employees to discover and book health and fitness courses nationwide, access employer-subsidized benefits, and find comprehensive wellness resources. For enterprises, the platform offers tools to integrate their own offerings, manage employee health budgets, track usage statistics, communicate with employees, and customize the platform's appearance.

SkinVision

Venture Round in 2013
SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.